Related Experiment Video
Updated: Jun 29, 2026

Controllable Ion Channel Expression through Inducible Transient Transfection
Published on: February 17, 2017
Sustained transgene expression using non-viral enzymatic systems for stable chromosomal integration
Fabien Palazzoli1, Elodie Carnus, Dominic J Wells
1Université François Rabelais de Tours, GICC, UFR des Sciences & Techniques, Parc de Grandmont, 37200 Tours, France.
This review explores non-viral gene delivery systems for gene therapy, focusing on enzymatic methods like site-specific endonucleases and phage/transposon systems for stable transgene expression and integration.
Area of Science:
- Biotechnology
- Molecular Biology
- Gene Therapy
Background:
- Gene delivery is crucial for biotechnology and gene therapy.
- Vector integration ensures sustained transgene expression.
- Current technologies include viral and non-viral approaches.
Purpose of the Study:
- To review non-viral enzymatic systems for DNA cassette integration.
- To summarize molecular and functional characteristics of these systems.
- To highlight properties, limitations, and safety considerations.
Main Methods:
- Review of non-viral enzymatic gene integration systems.
- Analysis of site-specific endonucleases and phage/transposon systems.
- Evaluation of safety, quality, IP, and economic aspects.
Main Results:
- Non-viral enzymatic systems offer alternatives to viral vectors for gene integration.
- Site-specific endonucleases and phage/transposon systems are key non-viral enzymatic approaches.
- Properties, limitations, and safety profiles vary among these systems.
Conclusions:
- Non-viral enzymatic systems show promise for gene therapy applications.
- Future developments are projected based on public and private interests.
- Addressing safety, quality, and economic factors is essential for technological advancement.
More Related Videos
06:10Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
Published on: May 9, 2025
10:13An Efficient In Vitro Transposition Method by a Transcriptionally Regulated Sleeping Beauty System Packaged into an Integration Defective Lentiviral Vector
Published on: January 12, 2018
Related Concept Videos
Transgenic Organisms
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Transgenic Plants
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...